Everyday Health on MSN
Exploring second-line therapies for CIDP
If your chronic inflammatory demyelinating polyneuropathy (CIDP) treatment has hit a plateau, new options like FcRn ...
Targeted therapies, including BTK inhibitors and venetoclax, have replaced chemoimmunotherapy as the first-line standard for CLL, emphasizing patient preference and risk factors in treatment decisions ...
Dr. Shune continues the case discussion by describing disease progression following second-line therapy and outlining her approach to third-line treatment selection in cGVHD. After initiating systemic ...
Real world data show multiple myeloma survival varies by treatment line and autologous stem cell transplant status. Read more ...
The treatment of metastatic colorectal cancer (mCRC) remains challenging. There has been substantial progress in understanding the molecular pathology of the disease that has led to meaningful ...
Onvansertib combined with FOLFIRI and Avastin shows dose-dependent improvements in tumor response and disease control for RAS-mutated mCRC. Cardiff Oncology plans a registrational trial to compare ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — Combination immunotherapy significantly improved outcomes vs. first-line chemotherapy for patients ...
Substitution monotherapy and add-on therapy were equally effective as a second-line treatment for women with idiopathic generalized epilepsy, with no significant differences in failure rates between ...
Antihistamines are the first-line treatment for chronic spontaneous urticaria (CSU). If antihistamines are unsuccessful, systemic therapies that suppress the immune system are the next option. CSU is ...
The discussion will cover the current CLL treatment landscape, including first-line and later-line options; the medical experts will review first-line treatments, approach to treatment selection, ...
Please provide your email address to receive an email when new articles are posted on . Incidences of hospitalizations and surgeries were lowest with the vedolizumab-adalimumab sequence in UC and CD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results